{"id":"amorolfine-5","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin irritation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Amorolfine works by competitively inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for the conversion of lanosterol to ergosterol. This leads to an accumulation of toxic compounds and ultimately results in the death of the fungal cells. Amorolfine is effective against a wide range of dermatophytes and yeasts.","oneSentence":"Amorolfine is an antifungal agent that inhibits the growth of fungi by interfering with the synthesis of ergosterol, an essential component of fungal cell membranes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:36.496Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Onychomycosis"}]},"trialDetails":[{"nctId":"NCT06254027","phase":"NA","title":"Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment","status":"UNKNOWN","sponsor":"Oystershell NV","startDate":"2024-03","conditions":"Onychomycosis","enrollment":132},{"nctId":"NCT02812043","phase":"PHASE4","title":"Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2016-08","conditions":"Non-dermatophyte Onychomycosis","enrollment":60},{"nctId":"NCT02679911","phase":"PHASE4","title":"Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2015-09","conditions":"Foot Dermatoses","enrollment":20},{"nctId":"NCT02705664","phase":"PHASE4","title":"Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1%","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2016-01","conditions":"Foot Dermatoses","enrollment":22},{"nctId":"NCT00938925","phase":"NA","title":"Effectiveness of Podiatry Care on Onychomycosis (EPOCAON)","status":"WITHDRAWN","sponsor":"University of Malaga","startDate":"2009-10","conditions":"Onychomycosis","enrollment":""},{"nctId":"NCT02549001","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis","status":"COMPLETED","sponsor":"Polichem S.A.","startDate":"2015-08-20","conditions":"Onychomycosis","enrollment":953},{"nctId":"NCT03098342","phase":"NA","title":"Comparison of Efficacy and Safety Between Methylene Blue-mediated Photodynamic Therapy and 5% Amorolfine Nail Lacquer for Toenail Onychomycosis Treatment","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2017-06-01","conditions":"Onychomycosis of Toenail","enrollment":42},{"nctId":"NCT01851590","phase":"PHASE4","title":"Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2013-10","conditions":"Onychomycosis","enrollment":129},{"nctId":"NCT01929187","phase":"NA","title":"A Randomized Study to Evaluate the Efficacy of Herbal Ingredients Combined With a Carrier System (Phytonail) Compared With Amorolfine 5% Nail Lacquer (Loceryl) in the Treatment of Toenail Onychomycosis","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2013-02","conditions":"Onycomycosis","enrollment":72},{"nctId":"NCT00459537","phase":"PHASE3","title":"Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-03","conditions":"Onychomycosis","enrollment":1029},{"nctId":"NCT01014637","phase":"PHASE4","title":"Efficacy, Safety and Cost-effectiveness of a Sequential Therapy With RV4104A Ointment, Ciclopiroxolamine Cream and Ciclopirox Film-forming Solution Compared With Amorolfine Nail Lacquer in Dermatophytic Onychomycosis","status":"UNKNOWN","sponsor":"Pierre Fabre Dermo Cosmetique","startDate":"2009-08","conditions":"Onychomycosis","enrollment":260}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":32,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Loceryl®"],"phase":"phase_3","status":"active","brandName":"amorolfine 5%","genericName":"amorolfine 5%","companyName":"Polichem S.A.","companyId":"polichem-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Amorolfine is an antifungal agent that inhibits the growth of fungi by interfering with the synthesis of ergosterol, an essential component of fungal cell membranes. Used for Onychomycosis.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}